PACKAGE LEAFLET: INFORMATION FOR THE USER. Amikacin 250 mg/ml Injection

Similar documents
PATIENT INFORMATION LEAFLET GENTAMICIN 10MG/ML SOLUTION FOR INJECTION OR INFUSION. and GENTAMICIN 40MG/ML SOLUTION FOR INJECTION OR INFUSION

Package leaflet: Information for the patient Genticin 80mg/2ml Solution for Injection Gentamicin

PACKAGE LEAFLET: INFORMATION FOR THE USER Gentamicin 40 mg/ml Injection

PACKAGE LEAFLET Page 1 of 6

PATIENT INFORMATION LEAFLET DYNA CEFPODOXIME 100 mg / DYNA CEFPODOXIME SUSPENSION:

Package leaflet: Information for the patient. Co-amoxiclav 250 mg/125 mg film-coated tablets Amoxicillin/clavulanic acid

AMLODIPINE 5 MG TABLETS AMLODIPINE 10 MG TABLETS Amlodipine

PACKAGE LEAFLET: INFORMATION FOR THE USER. AMOXICILLIN 250mg and 500mg CAPSULES BP Amoxicillin (as amoxicillin trihydrate)

1. WHAT CO-AMOXICLAV TABLETS IS AND WHAT IT IS USED FOR

Amoxicillin 250mg Hard Capsules Amoxicillin 500mg Hard Capsules

Package leaflet: Information for the user

2 What you need to know before you take Augmentin

New Zealand Consumer Medicine Information

Package leaflet: Information for the patient. FLUCLOXACILLIN 250MG/5ML ORAL SOLUTION Flucloxacillin

PACKAGE LEAFLET: INFORMATION FOR THE USER. Amlodipine 5 mg Tablets Amlodipine 10 mg Tablets (Amlodipine Besilate)

Package leaflet: Information for the patient. Co-amoxiclav 500 mg/125 mg film-coated tablets. amoxicillin/ clavulanic acid

Package leaflet: Information for the patient

Package leaflet: Information for the user. GENTAMICIN VISION 3 mg/ml eye drops, solution Gentamicin

PATIENT INFORMATION LEAFLET

B. PACKAGE LEAFLET 1

Health Products Regulatory Authority

READ THIS FOR SAFE AND EFFECTIVE USE OF YOUR MEDICATION PATIENT MEDICATION INFORMATION. Moxifloxacin tablets (as moxifloxacin hydrochloride)

PACKAGE LEAFLET: INFORMATION FOR THE USER

PACKAGE LEAFLET: INFORMATION FOR THE USER

Package leaflet: Information for the patient. Amoxicilline/Clavulaanzuur Torrent 500 mg/125 mg filmomhulde tabletten. Amoxicillin Clavulanic acid

SUMMARY OF PRODUCT CHARACTERISTICS. Cephacare flavour 50 mg tablets for cats and dogs. Excipients: For a full list of excipients, see section 6.1.

Gentamicin or Tobramycin for Peritonitis in Peritoneal Dialysis

PACKAGE LEAFLET: Information for the user. amlodipino cinfa 5 mg tablets

Package leaflet: Information for the user. Amlodipin Accord 10 mg tablets. Amlodipine

Package leaflet: Information for the user

Package leaflet: Information for the user. Amlodipin Aurobindo 10 mg tablets. Amlodipine

Amlodipin Bluefish 10 mg tablets. amlodipine

Package leaflet: Information for the patient. Desloratadine Cipla 5 mg film-coated tablets. Desloratadine

BIJSLUITER: INFORMATIE VOOR DE GEBRUIKER. Deslorasam 5 mg filmomhulde tabletten Desloratadine

LABELLING AND PACKAGE LEAFLET

B. PACKAGE LEAFLET 1

SUMMARY OF PRODUCT CHARACTERISTICS 1.B.1 SUMMARY OF PRODUCT CHARACTERISTICS

Summary of Product Characteristics

Summary of Product Characteristics

SUMMARY OF PRODUCT CHARACTERISTICS

PACKAGE LEAFLET Page 1 of 7

PACKAGE LEAFLET: INFORMATION FOR THE USER. GENTAMICIN VISION 3 mg/g eye ointment Gentamicin

[Version 8.1,01/2017] ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS

Withdrawal period: 93 days Milk: Not authorised for use in animals producing milk for human consumption.

1 TRADE NAME OF THE MEDICINAL PRODUCT. Gentamicin Paediatric 20mg/2ml Solution for Injection 2 QUALITATIVE AND QUANTITATIVE COMPOSITION

PACKAGE LEAFLET: INFORMATION FOR THE USER. Amlodipine 10 mg Tablets. (Amlodipine Besilate)

Package leaflet: Information for the user Augmentin 875 mg/125 mg film-coated tablets Amoxicillin/clavulanic acid

SUMMARY OF PRODUCT CHARACTERISTICS. Bottle of powder: Active substance: ceftiofur sodium mg equivalent to ceftiofur...

SUMMARY OF PRODUCT CHARACTERISTICS. Active substance: cefalexin (as cefalexin monohydrate) mg

For the treatment of infections caused by a wide range of Gram-positive and Gramnegative pathogenic bacteria including:

ANNEX III LABELLING AND PACKAGE LEAFLET

2. What you need to know before you take Doxycycline capsule

AMLODIPINE GENERICHEALTH

SUMMARY OF PRODUCT CHARACTERISTICS

Summary of Product Characteristics

DBL Doxycycline Doxycycline Hydrochloride (dox-i-sye-kleen)

Package leaflet: Information for the patient. Germentin 500 mg/125 mg film coated tablets Amoxicillin/clavulanic acid

ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS. Medicinal product no longer authorised

OFLOXACIN TABLETS MEDICATION GUIDE

PART IB1 SUMMARY OF PRODUCT CHARACTERISTICS OCTACILLIN

Blooms The Chemist Amlodipine / Atorvastatin

FDA-Approved Medication Guide MEDICATION GUIDE Moxifloxacin Hydrochloride Tablets (mox'' i flox' a sin hye'' droe klor' ide) Rx only

BOX 1. NAME OF THE VETERINARY MEDICINAL PRODUCT. Hymatil 300 mg/ml solution for injection for cattle and sheep Tilmicosin

SUMMARY OF PRODUCT CHARACTERISTICS

SUMMARY OF PRODUCT CHARACTERISTICS. Procaine penicillin Dihydrostreptomycin Sulfate

Summary of Product Characteristics

MEDICATION GUIDE FLOXIN [Flox in] (ofloxacin)

Minims Chloramphenicol

Package leaflet: Information for the user. Desloratadine Archie Samuel 5 mg filmomhulde tabletten Desloratadine

ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS

Irish Medicines Board

Keep this leaflet with your medicine. You may want to read it again. What this medicine is used for

SUMMARY OF PRODUCT CHARACTERISTICS

Package leaflet: Information for the user. Propofol 2 % (20 mg/1 ml) Fresenius emulsion for injection or infusion Propofol

SUMMARY OF PRODUCT CHARACTERISTICS

ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS

Package leaflet: Information for the user. AUGMENTIN DUO 400 mg/57 mg/5 ml powder for oral suspension Amoxicillin/clavulanic acid

Oral and intestinal candidiasis. As adjuvant treatment with other local nystatin preparations to prevent reinfection.

Amlodipine Pfizer 5 mg and 10 mg tablets Amlodipine

Therios 300 mg and 750 mg Palatable Tablets for Dogs

Day 90 Labelling, PL LABELLING AND PACKAGE LEAFLET

ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS

For a copy of a large print leaflet, Ph: Read this leaflet carefully before taking your medicine.

Moxifloxacin APOTEX Contains the active ingredient moxifloxacin (as hydrochloride monohydrate)

SUMMARY OF PRODUCT CHARACTERISTICS

Metacam is an anti-inflammatory medicine used in cattle, pigs, horses, dogs, cats and guinea pigs.

Summary of Product Characteristics

PACKAGE LEAFLET: INFORMATION FOR THE USER. Propofol 1% (10 mg/1 ml) Fresenius emulsion for injection or infusion Propofol

ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS

Prescription Label. Patient Name: Species: Drug Name & Strength: Directions (amount to give how often & for how long):

ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS 1/33

Veterinary Medicinal Product

Intravenous Antibiotic Therapy Information Leaflet

[09/2018] ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS

ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS

Prescription Label. Patient Name: Species: Drug Name & Strength: Directions (amount to give how often & for how long):

ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS

SUMMARY OF PRODUCT CHARACTERISTICS. 1. NAME OF THE VETERINARY MEDICINAL PRODUCT Emdocam 20 mg/ml solution for injection for cattle, pigs and horses

SUMMARY OF PRODUCT CHARACTERISTICS. Florgane 300 mg/ml Suspension for Injection for Cattle and Pigs

SUMMARY OF PRODUCT CHARACTERISTICS. NUFLOR 300 mg/ml solution for injection for cattle and sheep

Transcription:

PACKAGE LEAFLET: INFORMATION FOR THE USER Amikacin 250 mg/ml Injection Read all of this leaflet carefully before you start using this medicine. Keep this leaflet. You may need to read it again. If you have any further questions, ask your doctor or pharmacist. If any of the side effects gets serious, or if you notice any side effects not listed in this leaflet, please tell your doctor. In this leaflet: 1. What Amikacin Injection is and what it is used for 2. Before you use Amikacin Injection 3. How to use Amikacin Injection 4. Possible side effects 5. How to store Amikacin Injection 6. Further information 1. WHAT AMIKACIN INJECTION IS AND WHAT IT IS USED FOR Amikacin Injection is one of a group of antibiotic medicines called aminoglycosides. Amikacin Injection is used in the treatment of serious infections caused by bacteria sensitive to amikacin. 2. BEFORE YOU USE AMIKACIN INJECTION Do not use Amikacin Injection if you have shown signs of hypersensitivity (severe allergy) to amikacin, or any of the other ingredients listed in section 6, in the past if you suffer from a disorder called myasthenia gravis (severe weakness of certain muscles of the body) Tell your doctor if any of the above applies to you before this medicine is used. Take special care with Amikacin Injection if you have kidney problems if you have hearing difficulties or tinnitus (ringing or buzzing in the ears) if you have shown signs of allergy to any of the antibiotics related to amikacin (aminoglycosides) in the past If you have a known allergy to sulphites Amikacin should be used with caution in premature and neonatal infants. Tell your doctor if any of the above applies to you before this medicine is used. Taking/using other medicines Page 1 of 6

Special care is needed if you are taking/using other medicines, as some could interact with amikacin for example: diuretics (water tablets) such as furosemide and ethacrynic acid other antibiotics that can affect your kidneys, hearing or balance anaesthetics or muscle-relaxing drugs indomethacin (an anti-inflammatory medicine) other antibiotics called beta-lactamases such as penicillins or cephalosporins bisphosphonates; drugs used to treat loss of bone mass vitamin B1 (thiamine) platinum compounds used in chemotherapy such as cisplatin Please tell your doctor if you are taking or have recently taken any other medicines, including medicines obtained without a prescription. Pregnancy and breast-feeding Tell your doctor if you are pregnant, trying to become pregnant or breast-feeding. Your doctor will only use this medicine if the expected benefits outweigh any potential risk to your baby. Ask your doctor or pharmacist for advice before taking any medicine. Driving and using machines Do not drive or use machines if you experience any side effect (e.g. dizziness) which may lessen your ability to do so. Important information about some of the ingredients of Amikacin Injection This medicine contains sodium metabisulphite, which may rarely cause hypersensitivity (severe allergy) reactions and bronchospasm (breathing difficulties). This medicinal product contains less than 1 mmol (23 mg) sodium per dose, i.e. essentially sodium free. 3. HOW TO USE AMIKACIN INJECTION This medicine is usually injected into a muscle. It may also be given into a vein, either as an injection or (following dilution) as an infusion (drip). Amikacin can also be given into the peritoneum (abdominal cavity) during surgery, and can be used to wash out abscess cavities, the lung cavity and brain cavities. Your doctor will ensure you are well hydrated before and during treatment. Dose Your doctor will work out the correct dose of amikacin for you and how often it must be given. This may require blood tests before treatment. The dose will depend upon your age, the infection you have, how well your kidneys are working, if you have poor hearing and any other medicines you may be taking. It will usually be given to you two or three times a day, for up to 10 days. Page 2 of 6

Adults and children over 12 years: The usual dose is 15 mg per kg per day which is administered as a single dose or divided into two equal doses of 7.5 mg per kg administered every 12 hours. The total dose should not exceed 1.5 g. When treatment is given in to a vein it is usually administered over a 30 to 60 minute period. Children up to 12 years: The usual dose is 15 20 mg per kg of body weight once a day or divided into two equal doses of 7.5 mg per kg which is administered every 12 hours. Neonates: The initial dose is 10 mg per kg of body weight followed by 7.5 mg per kg every 12 hours. Premature infants: The recommended dosing in premature babies is 7.5 mg per kg every 12 hours. During treatment you may undergo blood tests and be asked to provide urine samples. You will possibly also have hearing tests before and during treatment to look for signs of side effects. Your doctor may change your dose depending upon the results of these tests. If you are given too much or too little Amikacin Injection This medicine will be given to you in a hospital, under the supervision of a doctor. It is unlikely that you will be given too much or too little, however, tell your doctor or nurse if you have any concerns. 4. POSSIBLE SIDE EFFECTS Like all medicines, amikacin can cause side effects, although not everybody gets them. If any of the following happens, tell your doctor immediately as these are all serious. You may need urgent medical attention or hospitalisation. Rare side-effects which may affect less than 1 person in 1000 are listed below: ringing in your ears or loss of hearing decrease in the amount of urine you produce Not known; numbers of sufferers cannot be estimated from available data are listed below: severe allergic reaction - you may experience a sudden itchy rash (hives), swelling of the hands, feet, ankles, face, lips, mouth or throat (which may cause difficulty in swallowing or breathing), and you may feel you are going to faint paralysis deafness sudden loss of breathing severe kidney failure These are serious side effects. You may need urgent medical attention. Page 3 of 6

If any of the following happens, tell your doctor as soon as possible: Uncommon side-effects which may affect more than 1 person in 1000 are listed below: skin rash nausea and vomiting an excessive build up of bacteria or yeast which are resistant to amikacin Rare side-effects which may affect less than 1 person in 1000 are listed below: dizziness or vertigo (spinning sensation) headache fever unusually low amount of red blood cells in the blood (anaemia) or excessive amounts of the white blood cells known as eosinophils in the blood (eosinophilia) low levels of magnesium in the blood abnormal tingling or pins and needles sensation muscle tremors joint pain low blood pressure itching or hives Amikacin may lead to changes in your kidney function. Your doctor may take blood and urine samples to monitor for changes such as increased levels of creatinine or nitrogen in the blood and protein or red/white blood cells in urine. Your doctor may also ask you to undergo hearing tests. If any of the side effects gets serious, or if you notice any side effects not listed in this leaflet, please tell your doctor. Reporting of side effects If you get any side effects, talk to your doctor, pharmacist or nurse. This includes any possible side effects not listed in this leaflet. You can also report side effects directly via: Yellow Card Scheme Website: www.mhra.gov.uk/yellowcard By reporting side effects you can help provide more information on the safety of this medicine. 5. HOW TO STORE AMIKACIN INJECTION Keep out of the reach and sight of children Expiry This medicine must not be used after the expiry date which is stated on the vial and carton after 'EXP'. Where only a month and year is stated, the expiry date refers to the last day of that month. Page 4 of 6

Storage The vials should be stored at, or below, 25 C. Unused portions of opened vials must not be stored for later use. Prepared injections or infusions should be used immediately, however, if this is not possible they can be stored for up to 24 hours. 6. FURTHER INFORMATION What Amikacin Injection contains The active substance is amikacin. Each millilitre (ml) of solution contains 250 milligrams (mg) of amikacin (as amikacin sulphate). The other ingredients are sodium citrate, sodium metabisulphite and Water for Injections. See section 2 for further information about sodium metabisulphite. What Amikacin Injection looks like and contents of the pack Amikacin Injection is a clear, colourless to pale yellow solution for injection which comes in glass containers called vials. It may be supplied in packs containing 5 x 500 mg/2 ml vials Marketing authorisation holder and manufacturer Hospira UK Limited, Horizon, Honey Lane, Hurley, Maidenhead, SL6 6RJ, UK This leaflet was last revised in 08/2017 Ref: gxak 1_1 ------------------------------------------------------------------------------------------------------- Amikacin 250 mg/ml Injection The following information is intended for medical or healthcare professionals only Further to the information included in section 3, practical information on the preparation/handling of the medicinal product is provided here. Incompatibilities Amikacin is incompatible with some penicillins and cephalosporins, amphotericin chlorothiazide sodium, erythromycin gluceptate, heparin, nitrofurantoin sodium, phenytoin sodium, thiopentone sodium and warfarin sodium, and depending on the composition and strength of the vehicle, tetracyclines, vitamins of the B group with vitamin C, and potassium chloride. Page 5 of 6

At times, amikacin may be indicated as concurrent therapy with other antibacterial agents in mixed or superinfections. In such instances, amikacin should not be physically mixed with other antibacterial agents in syringes, infusion bottles or any other equipment. Each agent should be administered separately. Instructions for use and handling Single use only Discard any unused contents The solution may darken from colourless to a pale yellow but this does not indicate a loss of potency. If required, suitable diluents for intravenous use are normal saline or 5% dextrose in water. Amikacin in concentrations of 0.25% (2.5 mg/ml) may be used satisfactorily as an irrigating solution in abscess cavities, the pleural space, the peritoneum and the cerebral ventricles. In use storage precautions Following dilution in 0.9% sodium chloride and 5% glucose solutions, chemical and physical in-use stability has been demonstrated for 24 hours at a temperature not above 25 C. From a microbiological point of view, the product should be used immediately. If not used immediately, in-use storage times and conditions prior to use are the responsibility of the user and would normally not be longer than 24 hours at 2 to 8 C, unless dilution has taken place in controlled and validated aseptic conditions. Ref: gxak 1_1 Page 6 of 6